Published: July 2017 as part of Policy Impact Unit

This report synthesizes dialogue generated by speakers at the Canada’s Drug Futures Forum and outlines recommendations for the next ten years of Canadian drug policy from over 200 attendees including policymakers, public health officials, law enforcement professionals, researchers, people who use drugs, and community organizers.

Published: May 2017 as part of Preventing Injecting by Modifying Existing Responses (PRIMER)

This article explores current challenges to contain the opioid epidemic and calls for various treatments that could reduce the epidemic including the scaling up of medication-assisted treatment (MAT).

Published: May 2017 as part of Policy Impact Unit

This policy brief from the CDPE and the Munk School of Global Affairs at the University of Toronto provides guidance to national governments seeking to align domestic legalization and regulation of recreational cannabis markets with their international legal obligations.

Published: September 2016 as part of Preventing Injecting by Modifying Existing Responses (PRIMER)

This study explores the methodology employed in the PRIMER study.

Published: April 2016 as part of Drug Policy Metrics Map

This commentary emphasizes the need to expand the range of indicators used to assess and improve drug policy effectiveness.

Published: April 2016 as part of Systematic Reviews on Drug Policy

This study is a systematic review and meta-analysis to examine the effectiveness of topiramate in treating cocaine use disorder.

Published: April 2016 as part of Preventing Injecting by Modifying Existing Responses (PRIMER)

This article examines the discrepancies between federal policy and local responses to drug-related harms to understand the impact of national drug policies in shaping local responses to drug-related harms among people who use drugs (PWID).

Published: February 2016 as part of Systematic Reviews on Drug Policy

This study published in the International Journal of Drug Policy (IJDP) finds that evidence does not, on the whole, suggest improved outcomes related to compulsory treatment approaches, with some studies suggesting potential harms.

Published: January 2016 as part of Drug Policy Metrics Map

This open letter outlines extensive scientific evidence that the indicators used to evaluate drug policy ignore some of the most important community impacts and provides a preliminary set of suggested indicators that allow for governments to better assess the health, security, development, and human rights impacts of their drug policies.

Published: August 2015 as part of #CannabisClaims

This summary report will equip readers with quick, easy, and evidence-based responses to commonly heard claims on cannabis use and regulation.